CRU Global
Our clinical partner CRU Global is a top-tier network of clinical research sites, with over 200 Phase I to III trials completed for Pfizer, Novartis, Merck (American), GSK, Amgen, AstraZeneca, and others. CRU Global has an excellent track record for rapid patient enrollment (often the top world-wide enroller in multi-site trials), with >95% recruitment targets met or exceeded, >95% patient retention, and industry-leading success/completion rates. CRU Global also offers medical writing, regulatory preparation and submission, and most other tasks involved in carrying a drug or device through clinical development.
Representative CRU Global clinical studies:
CRO | Sponsor | Therapy area | Protocol No. |
MSD Pharma Hungary Kft | MSD | Non Small Cell Lung Cancer | MK-7902-007-01 |
AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Colitis Ulcerosa | M16-066 |
PRA Magyarország Kft. | F. Hoffmann-La Roche AG | Hepatic Impairment | GP41174 |
IQVIA Biotech | Milestone Pharmaceuticals Inc. | Cardiovascular outcomes studies | NODE-303 |
IQVIA Biotech | Eli Lilly and Compary | Rheumatoid arthritis | I4V-MC-JAJA |
August Research | Cirius Therapeutics, Inc. | Diabetes/ obesity in diabetes | CTI-0602K-C013 |
PRA Magyarország Kft. | Bristol-Myers Squibb Company | Psoriatic Arthritis | IM011084 |
PAREXEL Magyarország Kft. | Pfizer Inc. | Diabetes/ obesity in diabetes | C3421005 |
PAREXEL Magyarország Kft. | Pfizer Inc. | Dermatitis | B7931022 |
MSD Pharma Hungary Kft | MSD | Non Small Cell Lung Cancer | MK-7902-007-01 |
Amgen Kft. | Amgen Kft. | Dermatitis | 20170755 |
AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Non Small Cell Lung Cancer | M14-239 |
AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Colitis Ulcerosa | M16-066 |
PSI CRO Hungary | Celgene International II Sàrl | Crohn Disease | RPC01-3203 |
PSI CRO Hungary | Celgene International II Sàrl | Crohn Disease | RPC01-3204 |
AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Colitis Ulcerosa | M16-067 |
Amgen Kft. | Amgen Kft. | Hypercholesterolemia | 20170625 |
AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Crohn Disease | M14-430 |
Worldwide Clinical Trials | KBP Biosciences Co. Ltd. | Hypertension | KBP-5074-2-001 |
Syneos Health UK Limited | Summit (Oxford) Limited | Clostridium | SMT19969/C004 |
AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Psoriatic Arthritis | M15-998 |
HungaroTrial | MedDay Pharmaceuticals SA | Hepatic Impairment | OP107719.MED |
HungaroTrial | MedDay Pharmaceuticals SA | Renal Impairment | OP107819.MED |
KCR S.A. | BiondVax Pharmaceuticals Ltd. | Influenza | BVX-010_2 |
CPS Cortex Kft. | Abivax | Rheumatoid arthritis | ABX464-301 |
PRA Magyarország Kft. | Estetra SPRL | Hepatic Impairment | MIT-Do001-C102 |
PRA Magyarország Kft. | Bristol-Myers Squibb Company | Hepatic Impairment | IM011-062 |
PRA Magyarország Kft. | BIAL | Hepatic Impairment | BIA-51058-113 |
PRA Magyarország Kft. | BIAL | Renal Impairment | BIA-51058-114 |
PSI CRO Hungary | Celgene International II Sàrl | Crohn Disease | RPC01-3202 |
Cromos Pharma | Umecrine Cognition AB | Hepatic Impairment | UCAB-CT-02 |
COVANCE Hungária Kft. | CSL Behring GmBH | Acute Coronary Syndrome | CSL12_3001 |
MSD Pharma Hungary Kft | MSD | Chronic cough | MK 7264-027 |
MSD Pharma Hungary Kft | MSD | Chronic cough | MK 7264-030 |
Cromos Pharma | Umecrine Cognition AB | Hepatic Impairment | UCAB-CT-02 |
AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Rheumatoid arthritis | M16-560 |
PRA Magyarország Kft. | Bristol-Myers Squibb Company | Hepatic Impairment | CV013026 |
AstraZeneca | AstraZeneca | Cardiovascular outcomes studies | D169CC00001 |
Pfizer Hungary | Pfizer Inc. | Non Small Cell Lung Cancer | B991023 |
TFS | Novartis Hungária Kft. | Psoriatic Arthritis | CAIN457F2354 |
PRA Magyarország Kft. | Avanir Pharmaceuticals Inc. | Alzheimer Disease | 17-AVP-786-305 |
PAREXEL Magyarország Kft. | Pfizer Inc. | Non Small Cell Lung Cancer | B9991025 |
TFS | Galapagos NV | Dermatitis | MOR106-CL-201 |
AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Crohn Disease | M14-430 |
AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Small Cell Lung Cancer | M16-298 |
PRA Magyarország Kft. | Bristol-Myers Squibb Company | Renal Impairment | MB130065 |
AstraZeneca | AstraZeneca | Other cardiovascular | D9484C00001 |
Quintiles Switzerland Sárl | GlaxoSmithKline Kft. | COPD | 2014N206201_00 |
AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Crohn Disease | M14-431 |
AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Crohn Disease | M14-431 |
AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Crohn Disease | M14-433 |
AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Crohn Disease | M14-433 |
inVentiv Health Hungary | Pfizer Inc. | Hematology | A4091061 |
ZAK-Pharma | Boehringer Ingelheim | Alzheimer Disease | BI 425809 |
PAREXEL Magyarország Kft. | Pfizer Inc. | Cardiovascular outcomes studies | B1521021 |
AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Rheumatoid arthritis | M16-763 |
Amgen Kft. | Amgen Kft. | Cardiovascular outcomes studies | 20130295 |
MSD Pharma Hungary Kft | MSD | Non Small Cell Lung Cancer | MK-3475-715 |
ICON Klinikai Kutató Kft. | Pfizer Inc. | Dermatitis | B7451015 |
PAREXEL Magyarország Kft. | UCB Pharma Ltd | Psoriasis | PS0014 |
Janssen-Cilag Kft. | Janssen-Cilag International N.V. | Schizophrenia | R092670PSY3015 |
Janssen-Cilag Kft. | Janssen-Cilag International N.V. | Schizophrenia | R092670PSY3015 |
Janssen-Cilag Kft. | Janssen-Cilag International N.V. | Schizophrenia | R092670PSY3015 |
Janssen-Cilag Kft. | Janssen-Cilag International N.V. | Schizophrenia | R092670PSY3015 |
Medpace Inc | DalCore Pharma UK Ltd. | Cardiovascular outcomes studies | DAL-301 |
ICON Klinikai Kutató Kft. | Pfizer Inc. | Clostridium | B5091007 |
PAREXEL Magyarország Kft. | UCB Pharma Ltd | Psoriasis | PS0013 |
AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Rheumatoid arthritis | M16-063 |
PRA Magyarország Kft. | Gan & Lee Pharmaceuticals | Diabetes/ obesity in diabetes | GL-GLAT1-3001 |
Clinipace Worldwide | SHIELD Therapeutics | Anemia | ST10-01-304 |
PAREXEL Magyarország Kft. | AstraZeneca | Asthma | D3741C00007 |
PAREXEL Magyarország Kft. | AstraZeneca | Asthma | D3741C00007 |
PSI CRO Hungary | Basilea Pharmaceutica International Ltd | Dermatitis | BPR-CS-008 |
AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Rheumatoid arthritis | MTX-IR M14-465 |
AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Rheumatoid arthritis | MTX-native M13-545 |
ICON Klinikai Kutató Kft. | Pfizer Inc. | Dermatitis | B7451012 |
Novartis Hungária Kft. | Novartis Hungária Kft. | Asthma | CQVM149B2301 |
HungaroTrial | Chiesi Farmaceutici S.p.A. | COPD | CLI-05993BA102 |
ZAK-Pharma | Boehringer Ingelheim | Embolic Stroke | BI1160.189 |
PAREXEL Magyarország Kft. | Pfizer Inc. | Rheumatoid arthritis | B7984006 |
inVentiv Health Hungary | Pfizer Inc. | Low Back Pain | A4091059 |
INC Research UK Limited | Biotest AG | Hematology | 992 |
INC Research UK Limited | Biotest AG | Hematology | 992 |
AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Non Small Cell Lung Cancer | M14-359 |
MSD Pharma Hungary Kft | Merck Sharp and Dohme | Non Small Cell Lung Cancer | MK-3475-024 |
PRA Magyarország Kft. | Mitshubishi Tanabe Pharma | Hepatic Impairment | MCI-186-E05 |
KCR S.A. | BiondVax Pharmaceuticals Ltd. | Influenza | BVX-010 |
COVANCE Hungária Kft. | AstraZeneca | Diabetes/ obesity in diabetes | D5670C00007 |
Worldwide Clinical Trials | Proximagen Ltd. | Osteoarthritis | 167700-004CL |
ZEINCRO | CERENIS Therapeutics | NASH | PROT-CER-209-CLIN-002 |
ZEINCRO | CERENIS Therapeutics | NASH | PROT-CER-209-CLIN-002 |
Worldwide Clinical Trials | Proximagen Ltd. | Osteoarthritis | 167700-004CL |
Medpace Inc | IONIS PHARMACEUTICALS, INC. | Diabetes/ obesity in diabetes | IS137CS2 |
Medpace Inc | Ironwood Pharmaceuticals, Inc. | Gout | RDEA594-401 |
AstraZeneca | AstraZeneca | COPD | D5970C00002 |
Worldwide Clinical Trials | Tricida Inc. | Nephropathy | TRCA-301 |
inVentiv Health Hungary | Pfizer Inc. | Rheumatoid arthritis | A3921192 |
Argint International | Novimmun SA | Rheumatoid arthritis | AI-CF010b |
PAREXEL Magyarország Kft. | Pfizer Inc. | Rheumatoid arthritis | B7921005 |
AstraZeneca | AstraZeneca | Asthma | D2500C00003 |
Worldwide Clinical Trials | Relypsa Inc. | Hypertension | RLY5016-207 |
AstraZeneca | AstraZeneca | COPD | PT009002-01 |
AstraZeneca | AstraZeneca | Asthma | D3250C00038 |
AstraZeneca | AstraZeneca | Asthma | D3250C00038 |
CPS Cortex Kft. | Meditop Pharmaceutical Ltd. | Other | KZ-PKP-092016 |
KCR S.A. | Luitpold Pharmaceuticals Inc. | Hematology | 1VIT14039 |
inVentiv Health Hungary | Pfizer Inc. | Dermatitis | B7451006 |
INC Research UK Limited | HAL Allergy B.V. | Allergic Rhinitis | PM/0041 |
COVANCE Hungária Kft. | Polichem S.A. | pattern baldness | PM1541 |
ICON Klinikai Kutató Kft. | Mereo BioPharma 1 Ltd | COPD | MBCT206 |
PRA Magyarország Kft. | Amgen Kft. | Rheumatoid arthritis | 20130108 |
PSI CRO Hungary | Achaogen Inc. | Urinary infection | ACHN-490-009 |
AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Rheumatoid arthritis | Biologics-IR M13-542 |
Medpace Inc | Zavanta | Urinary infection | ZTI-01-200 |
COVANCE Hungária Kft. | Motif BiosSciences Inc. | ABSSI | ICL-24-ABSSSI2 |
MSD Pharma Hungary Kft | Merck Sharp and Dohme | Diabetes/ obesity in diabetes | MK431-838 |
PSI CRO Hungary | Melinta Therapeutics | CABP | ML-3341-306 |
Medpace Inc | IONIS PHARMACEUTICALS, INC. | Diabetes/ obesity in diabetes | 449884-CS3 |
Orion LR Ltd. | Chiesi Farmaceutici S.p.A. | COPD | CCD-06302AA1-01 |
Servier Hungária Kft. | Servier Hungária Kft | Hematology | CL1-55746-001 |
INC Research UK Limited | Pharmaxis | Cystic Fibrosis | DPM-CF-303 |
PPD Magyarország Kft. | Nabriva Therapeutics US, Inc. | CABP | NAB-BC-3781-3101 |
inVentiv Health Hungary | Pearl Therapeutics, Inc. | COPD | PT010005 |
Pharm-Olam (Hungary) Ltd. | Boehringer Ingelheim | Diabetes/ obesity in diabetes | BI 124572 |
BioRasi LLC | BioRasi LLC | Other | ZIN-130-1504 |
PSI CRO Hungary | Paratek Pharma, LLC, | CABP | PTK0796-CABP-1200 |
Quintiles Magyarország Kft. | F. Hoffmann-La Roche AG | COPD | WB29804 |
INC Research UK Limited | Vectura Group Plc | Asthma | Vectura_VR475 |
PSI CRO Hungary | Paratek Pharma, LLC, | Dermatitis | PTK0796-ABSI-1108 |
Novartis Hungária Kft. | Novartis Hungária Kft. | Asthma | CQGE031B2204 |
MSD Pharma Hungary Kft | Merck Sharp and Dohme | Head and Neck Cancer | MK-3475-048 |
MSD Pharma Hungary Kft | Merck Sharp and Dohme | Head and Neck Cancer | MK-3475-040 |
AstraZeneca | AstraZeneca | Diabetes/ obesity in diabetes | D1689C0014 |
ICON Klinikai Kutató Kft. | Chiesi Farmaceutici S.p.A. | COPD | CCD-05993AA1-07 |
GlaxoSmithKline Kft. | GlaxoSmithKline Kft. | Diabetes/ obesity in diabetes | GLP116174 |
Worldwide Clinical Trials | Ablynx NV | Rheumatoid arthritis | ALX0061-C203 |
Medpace Inc | Astellas Pharma Europe | Diabetes/diabetic nephropathy | 8232-CL-0004 |
Medpace Inc | Astellas Pharma Europe | Diabetes/diabetic nephropathy | 8232-CL-0004 |
AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Non Small Cell Lung Cancer | M11-089 |
Worldwide Clinical Trials | Ablynx NV | Rheumatoid arthritis | ALX0061-C202 |
Worldwide Clinical Trials | Ablynx NV | Rheumatoid arthritis | ALX0061-C202 |
Worldwide Clinical Trials | Ablynx NV | Rheumatoid arthritis | ALX-0061 C201 |
Medpace Inc | Coherus Biosciences, Inc. | Rheumatoid arthritis | CHS-0214-02 |
Janssen-Cilag Kft. | Janssen-Cilag International N.V. | Type 2 diabetes | 28431754DIA4003 |
AstraZeneca | AstraZeneca | Asthma | ‘BISE’ D3250C00032 |
AstraZeneca | AstraZeneca | Other | D4281C00001 |
GlaxoSmithKline Kft. | GlaxoSmithKline Kft. | COPD | CTT116853 |
TFS | GW Pharma | Chronic Pain in Cancer | GWCA0999 |
Medpace Inc | IONIS PHARMACEUTICALS, INC. | Hyperlipidemia/ dyslipidemia | ISIS 304801-CS6 |
PAREXEL Magyarország Kft. | Pfizer Inc. | Type 2 diabetes | B1521017 |
PAREXEL Magyarország Kft. | Pfizer Inc. | Type 2 diabetes | B1521017 |
Amgen Kft. | Amgen Kft. | LDL-C abnormal lipid | 20130385 |
MSD Pharma Hungary Kft | Merck Sharp and Dohme | Non Small Cell Lung Cancer | MK-3475-010 |
Quintiles Magyarország Kft. | Eli Lilly and Compary | Diabetes/ obesity in diabetes | H9X-MC-GBDX |
PAREXEL Magyarország Kft. | Synta Pharmaceuticals Corp. | Non Small Cell Lung Cancer | Galaxy 2 / 9090-14 |
Janssen-Cilag Kft. | Janssen-Cilag International N.V. | COPD | 49095397OPD2001 |
AstraZeneca | AstraZeneca | Asthma | D589SC00001 |
AstraZeneca | AstraZeneca | Asthma | D589SC00003 SYGMA2 |
PAREXEL Magyarország Kft. | Synta Pharmaceuticals Corp. | Non Small Cell Lung Cancer | Galaxy 2 / 9090-14 |
Medpace Inc | Nephrogenex Inc. | Diabetes/diabetic nephropathy | PYR-311 |
AstraZeneca | AstraZeneca | Asthma | D2210C00007 |
GlaxoSmithKline Kft. | GlaxoSmithKline Kft. | COPD | DB2116961 |
Chiltern International | Chiesi Farmaceutici S.p.A. | COPD | CCD-1207-PR-0091 |
Chiltern International | Chiesi Farmaceutici S.p.A. | COPD | CCD-1207-PR-0091 |
Amgen Kft. | Amgen Kft. | Osteoporosis | 20101217 |
GlaxoSmithKline Kft. | GlaxoSmithKline Kft. | COPD | 201211 SGRQ |
Chiltern International | Chiesi Farmaceutici S.p.A. | COPD | CCD-1208-PR-0090 |
PRA Magyarország Kft. | Hanmi Pharmaceutical | Type 2 diabetes | HM-EXC-204 |
TFS | GW Pharma | Chronic Pain in Cancer | GWCA1103 |
AstraZeneca | AstraZeneca | COPD | D3251C00003 |
TFS | GW Pharma | Chronic Pain in Cancer | GWCA1103 |
COVANCE Hungária Kft. | MSD | Type 2 diabetes | MK-8835-001 |
ICON Klinikai Kutató Kft. | Pfizer Inc. | SPA | A3921119 |
Medpace Inc | Shionogi Inc. | Opioid Indication Constipation | 1326V9235 |
Medpace Inc | Omthera Pharmaceuticals | Hypertriglyceridemia | OM-EPA-011 |
Medpace Inc | Omthera Pharmaceuticals | Hypertriglyceridemia | OM-EPA-011 |
Janssen-Cilag Kft. | Janssen-Cilag International N.V. | Type 2 diabetes | 28431754DIA4003 |
PRA Magyarország Kft. | Hanmi Pharmaceutical | Type 2 diabetes | HM-EXC-203 |
PRA Magyarország Kft. | Ferring Pharmaceuticals | Constipation | 81 |
TFS | Aquinox | COPD | AQX-1125-202 |
Worldwide Clinical Trials | NEOVACS SA | Rheumatoid arthritis | TNF-K006 |
Medpace Inc | Kowa Research Europe Ltd. | LDL-C abnormal lipid | K-877-201 |
PRA Magyarország Kft. | Ferring Pharmaceuticals | Constipation | 80 |
Janssen-Cilag Kft. | Janssen-Cilag International N.V. | Type 2 diabetes | 28431754-DIA-3011 |
Scope International | Develco Pharma | Opioid Indication Constipation | 0176/DEV |
Scope International | Develco Pharma | Opioid Indication Constipation | 0177/DEV |
Amgen Kft. | Amgen Kft. | LDL-C with CV outcome | 20110118 |
Amgen Kft. | Amgen Kft. | LDL-C with CV outcome | 20110118 |
Medpace Inc | Helsinn Therapeutics | Non Small Cell Lung Cancer | HT-ANAM-302 |
Quintiles Magyarország Kft. | Takeda Global Research | Diabetes/diabetic nephropathy | TAK-875-302 |
Quintiles Magyarország Kft. | Mitshubishi Tanabe Pharma | Diabetes/diabetic nephropathy | MT-3995-07 |
Quintiles Magyarország Kft. | Vertex Pharmaceutical | Rheumatoid arthritis | VX11-509-102 |
Quintiles Magyarország Kft. | Thrombosis Research Institute | Other | TRI08888-GARFILED |
Medpace Inc | Helsinn Therapeutics | Non Small Cell Lung Cancer | HT-ANAM-301 |
Medpace Inc | Helsinn Therapeutics | Non Small Cell Lung Cancer | HT-ANAM-303 |
Worldwide Clinical Trials | Boehringer Ingelheim | Type 2 diabetes | BI 1245.25 |
PAREXEL Magyarország Kft. | Eli Lilly and Compary | Type 2 diabetes | 108440 |
PAREXEL Magyarország Kft. | Eli Lilly and Compary | Type 2 diabetes | 108440 |
Medpace Inc | ChemoCentryx Inc. | Diabetes/diabetic nephropathy | CL005_140 |
PAREXEL Magyarország Kft. | GlaxoSmithKline Kft. | COPD | HZC113782 |
Syneos Health UK Limited | Institut de Recherches Internationales SERVIER (I.R.I.S.) | Chronic Venous Disease | CL3-05682-109 |
INC Research UK Limited | Urovant Sciences GmbH | Overactive bladder | RVT-901-3004 |
Accelovance Europe | Zeno Pharmaceuticals Inc. | Non Small Cell Lung Cancer | ZN-e4-001 |
INC Research UK Limited | Urovant Sciences GmbH | Overactive bladder | RVT-901-3003 |
PRA Magyarország Kft. | Gilead Sciences Inc. | Rheumatoid arthritis | GS-US-417-0303 |
PRA Magyarország Kft. | Gilead Sciences Inc. | Rheumatoid arthritis | GS-US-417-0302 |
PRA Magyarország Kft. | UCB Pharma Ltd | SPA | AS0006 |
AbbVie Gyógyszerkereskedelmi | AbbVie Inc. | Rheumatoid arthritis | JAKMTXIR2 |
Linical Europe GmbH | Sun Pharmaceutical | Other | CLR_15_02 |
COVANCE Hungária Kft. | Incyte Corporation | Non Small Cell Lung Cancer | INCB 39110-205 |
COVANCE Hungária Kft. | Ignyta Pharma | Non Small Cell Lung Cancer | RXDX-101-02 |
Inamed GmbH (Trial Masters) | Actavis Group PTC | Asthma | ACT-2014-075 |